Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Consistent iconography across projects continues to challenge design teams working on multiple platforms. Icons8 offers one ...